+121.6%
NEE vs MRNA
+786.4%
-664.8%
-45.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -2.2% | +1.8% | -0.4% |
| 7D | -2.0% | -12.7% | +10.7% | -1.7% |
| 30D | +6.6% | -20.7% | +27.3% | +7.0% |
| 3M | -1.1% | +46.3% | -47.4% | -2.3% |
| 6M | -4.1% | +305.2% | -309.3% | -10.0% |
| YTD | +6.2% | +561.2% | -555.0% | -3.1% |
| 1Y | +1.8% | +772.1% | -770.3% | -8.4% |
| 3Y | +59.1% | +147.0% | -87.9% | +49.1% |
| 5Y | +8.1% | -26.1% | +34.2% | +4.8% |
| All | +121.6% | +786.4% | -664.8% | +92.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling